Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Robin

Showing results (241-250 of 297) with videos related to

Pageof 30
Sort By:
American Journal of Medical Genetics|January 2, 1996
Frontonasal malformation and cloacal exstrophy: a previously unreported associationN H Robin, J A Neidich, L D Bason, et al.
Nature Genetics|November 1, 1994
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndromeM Muenke, U Schell, A Hehr, et al.
American Journal of Medical Genetics. Part A|January 18, 2022
Near complete deletion of KMT2D in a college studentCatherine Gooch, Jaclyn Paige Souder, Matthew L Tedder, et al.
American Journal of Medical Genetics. Part A|October 28, 2011
Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disordersFady M Mikhail, Edward J Lose, Nathaniel H Robin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 15, 2013
The recurrent distal 22q11.2 microdeletions are often de novo and do not represent a single clinical entity: a proposed categorization systemFady M Mikhail, Rachel D Burnside, Brooke Rush, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeksS Senan, R Rampling, M A Graham, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 20, 2023
DLG2 intragenic exonic deletions reinforce the link to neurodevelopmental disorders and suggest a potential association with congenital anomalies and dysmorphismYunjia Chen, Ender Karaca, Nathaniel H Robin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trialM A Graham, S Senan, H Robin, et al.
Chest|June 25, 2008
Genetic and reproductive knowledge among adolescents and adults with cystic fibrosisGrace H Houser, Cheryl L Holt, J P Clancy, et al.
Human Genetics|October 6, 1998
Molecular characterization and delineation of subtle deletions in de novo "balanced" chromosomal rearrangementsA Kumar, L A Becker, T W Depinet, et al.
Pageof 30

Showing results (241-250 of 297) with videos related to

Sort By:
Pageof 30
American Journal of Medical Genetics|January 2, 1996
Frontonasal malformation and cloacal exstrophy: a previously unreported associationN H Robin, J A Neidich, L D Bason, et al.
Nature Genetics|November 1, 1994
A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndromeM Muenke, U Schell, A Hehr, et al.
American Journal of Medical Genetics. Part A|January 18, 2022
Near complete deletion of KMT2D in a college studentCatherine Gooch, Jaclyn Paige Souder, Matthew L Tedder, et al.
American Journal of Medical Genetics. Part A|October 28, 2011
Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disordersFady M Mikhail, Edward J Lose, Nathaniel H Robin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 15, 2013
The recurrent distal 22q11.2 microdeletions are often de novo and do not represent a single clinical entity: a proposed categorization systemFady M Mikhail, Rachel D Burnside, Brooke Rush, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeksS Senan, R Rampling, M A Graham, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 20, 2023
DLG2 intragenic exonic deletions reinforce the link to neurodevelopmental disorders and suggest a potential association with congenital anomalies and dysmorphismYunjia Chen, Ender Karaca, Nathaniel H Robin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trialM A Graham, S Senan, H Robin, et al.
Chest|June 25, 2008
Genetic and reproductive knowledge among adolescents and adults with cystic fibrosisGrace H Houser, Cheryl L Holt, J P Clancy, et al.
Human Genetics|October 6, 1998
Molecular characterization and delineation of subtle deletions in de novo "balanced" chromosomal rearrangementsA Kumar, L A Becker, T W Depinet, et al.
Pageof 30